Amendment AA2-AB599

AB599-AA2,37,17 (3) Prosecution. (a) A person who is acting in accordance with this section and s. 73.17 or 73.18 may not be prosecuted for a criminal offense under this chapter, or under any municipal ordinance that prohibits conduct that is the same as that prohibited under this chapter, for the possession, manufacture, distribution, or delivery of marijuana or possession with the intent to manufacture, distribute, or deliver marijuana.

AB599-AA2,38,2 (b) A licensed entity or an agent or employee of a licensed entity who possesses, manufactures, distributes, or delivers marijuana or possesses with the intent to manufacture, distribute, or deliver marijuana in violation of s. 73.17 or in violation of a rule promulgated under s. 73.17 may not be prosecuted under this chapter unless the person is referred to the district attorney for the county in which the violation occurred by the medical marijuana regulatory commission and may not be prosecuted under a municipal ordinance that prohibits the same conduct as is prohibited under this chapter unless the person is referred to local law enforcement by the medical marijuana regulatory commission.

AB599-AA2,42 Section 42. 961.38 (title) of the statutes is amended to read:

AB599-AA2,38,4 961.38 (title) Prescriptions and recommendations for medical use.

AB599-AA2,43 Section 43. 961.38 (1p) of the statutes is created to read:

AB599-AA2,38,8 961.38 (1p) A dispensary licensed under s. 73.17 may dispense medical marijuana to a person with a valid written hard copy or electronic recommendation and a valid registry identification card in accordance with s. 73.18.

AB599-AA2,44 Section 44. 961.385 (1) (aj) of the statutes is amended to read:

AB599-AA2,38,13 961.385 (1) (aj) “Patient" means an individual or animal for whom a monitored prescription drug is prescribed or, to whom a monitored prescription drug is dispensed or administered, or for whom the use of medical marijuana is recommended under s. 73.18 (2).

AB599-AA2,45 Section 45. 961.385 (2) (intro.) of the statutes is amended to read:

AB599-AA2,38,18 961.385 (2) (intro.) The board shall establish by rule a program for monitoring the dispensing of monitored prescription drugs and the making of recommendations for the use of, and issuance of registry identification cards for, medical marijuana. The program shall do all of the following:

AB599-AA2,46 Section 46. 961.385 (2) (am) and (an) of the statutes are created to read:

AB599-AA2,38,22 961.385 (2) (am) Require a practitioner to generate a record documenting each recommendation made by the practitioner for the use of medical marijuana under s. 73.18 (2).

AB599-AA2,38,24 (an) Require the medical marijuana regulatory commission to generate a record documenting the issuance of a registry identification card under s. 73.18 (3).

AB599-AA2,47 Section 47. 961.385 (2) (b) of the statutes is amended to read:

AB599-AA2,39,3 961.385 (2) (b) Identify specific data elements to be contained in a record documenting the dispensing of a monitored prescription drug, including the method of payment and, subject to sub. (2m), the name recorded under s. 450.11 (1b) (bm).

AB599-AA2,39,7 (bm) In identifying specific data elements, the board shall under pars. (b), (bc), and (bd), consider data elements identified by similar programs in other states and shall ensure, to the extent possible, that records generated by the program are easily shared with other states.

AB599-AA2,48 Section 48. 961.385 (2) (bc) and (bd) of the statutes are created to read:

AB599-AA2,39,11 961.385 (2) (bc) Identify specific data elements to be contained in a record documenting the making of a recommendation for the use of medical marijuana under s. 73.18 (2).

AB599-AA2,39,13 (bd) Identify specific data elements to be contained in a record documenting the issuance of a registry identification card under s. 73.18 (3).

AB599-AA2,49 Section 49. 961.385 (2) (cm) 3. a. of the statutes is amended to read:

AB599-AA2,39,20 961.385 (2) (cm) 3. a. The state board or agency, agency of another state, law enforcement agency, or prosecutorial unit makes a written request for the record and is engaged in an active and specific investigation or prosecution of a violation of any state or federal law involving a monitored prescription drug or any state or federal law involving marijuana, and the record being requested is reasonably related to that investigation or prosecution.

AB599-AA2,50 Section 50. 961.385 (2) (cs) 1. of the statutes is amended to read:

AB599-AA2,40,2 961.385 (2) (cs) 1. Require that a patient's records under the program be reviewed before the practitioner issues a prescription order for the patient or before the practitioner makes a recommendation to the patient for the use of medical marijuana under s. 73.18 (2). The review required under this subdivision may be performed by the practitioner or by the practitioner's agent in accordance with applicable standards of practice. This subdivision does not apply after April 1, 2025.

AB599-AA2,51 Section 51. 961.385 (2) (cs) 2. (intro.), b., c. and d. of the statutes are amended to read:

AB599-AA2,40,7 961.385 (2) (cs) 2. (intro.) The requirement requirements under subd. 1. that a patient's records under the program be reviewed before the practitioner issues a prescription order for the patient does do not apply if any of the following is true:

AB599-AA2,40,10 b. The practitioner is issuing a prescription order is for a monitored prescription drug for a number of doses that is intended to last the patient 3 days or less and is not subject to refill.

AB599-AA2,40,11 c. The A monitored prescription drug is lawfully administered to the patient.

AB599-AA2,40,15 d. Due to emergency, it is not possible to review the patient's records under the program before the practitioner issues a prescription order for the patient or before the practitioner makes a recommendation to the patient for the use of medical marijuana under s. 73.18 (2).

AB599-AA2,52 Section 52. 961.55 (8) (c) of the statutes is created to read:

AB599-AA2,40,18 961.55 (8) (c) A license from the medical marijuana regulatory commission under s. 73.17.”.

AB599-AA2,40,19 (End)